Drug Trends triangulates data from various sources to monitor trends in drug use and related harms in Australia.
Information from annual interviews with people who regularly inject drugs (Illicit Drug Reporting System; IDRS) and who regularly use ecstasy and other stimulants (Ecstasy and Related Drugs Reporting System; EDRS) recruited across all jurisdictions in Australia are used alongside analyses of routinely-collected indicator data (e.g., helpline calls, drug treatment episodes) to describe changes in drug use and harm across Australia over time.
National-level data (e.g., drug-related mortality and hospitalisations) are also regularly reported on to describe country-level trends in drug-related harms (National Illicit Drug Indicators Project; NIDIP).
Availability of substances on online drug marketplaces operating on the ‘dark net’ are monitored regularly to capture trends in online availability of illicit and emerging substances (Drugs and New Technologies; DNeT).
For news and research findings from the Drug Trends team please subscribe to the Drug Trends email newsletter.
Interested in accessing existing interview data to conduct analyses or requesting additional data be asked of the participants in the Illicit Drug Reporting System (IDRS) or Ecstasy and Related Drugs Reporting System (EDRS)? Please contact the Drug Trends team (firstname.lastname@example.org) for more information.
External chief investigators:
Professor Paul Dietze, Burnet Institute
Associate Professor Raimondo Bruno, University of Tasmania
Professor Rosa Alati, University of Queensland
Professor Simon Lenton, National Drug Research Institute